Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model

By sjmartinez • April 5, 2023

Zhang P, Miyata KN, Nast CC, LaPage JA, Mahoney M, Nguyen S, Khan K, Wu Q, Adler SG, Dai T. Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model. Perit Dial Int. 2023 Mar;43(2):159-167. doi: 10.1177/08968608221116956. Epub 2022 Aug 9. PMID: 35946050.

Tags: Angiogenesis, fibrosis, Harbor UCLA, JAK inhibitor, Nephrology, peritoneal dialysis, peritoneal membrane, Publications

Reply: Keto CTA Study

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Reply: Keto CTA Study. JACC Adv. 2025 May 7;4(7):101862.[...]

Mild to moderate COPD, vitamin D deficiency, and longitudinal bone loss: The MESA study

Ghotbi E, Hathaway QA, Hadidchi R, Momtazmanesh S, Bancks MP, Bluemke DA, Barr RG, Post WS, Budoff M, Smith BM, Lima JAC, Demehri S. Mild[...]

Dietary Protein Intake Recommendations for Patients with Non-Dialysis Dependent CKD: What Should Healthcare Providers Do?

Kovesdy CP, Brunori G, Fouque D, Friedman AN, Garibotto G, Ikizler TA, Kalantar-Zadeh K, Kistler BM, Koppe L, Kopple JD, Kuhlmann MK, Lambert K, Mak[...]